0001895262false00018952622025-05-082025-05-080001895262us-gaap:CommonStockMember2025-05-082025-05-080001895262ne:Tranche1WarrantsMember2025-05-082025-05-080001895262ne:Tranche2WarrantsMember2025-05-082025-05-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
__________________________________________
FORM 8-K 
__________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (date of earliest event reported): May 8, 2025
__________________________________________
NOBLE CORPORATION plc
(Exact name of registrant as specified in its charter)
England and Wales 001-41520 98-1644664
(State or other jurisdiction of incorporation) (Commission file number) (I.R.S. employer identification no.)
2101 City West Boulevard,Suite 600,Houston,Texas77042
(Address of principal executive offices)(Zip code)
Registrant’s telephone number, including area code: 281 276-6100
__________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
A Ordinary Shares, par value $0.00001 per shareNENew York Stock Exchange
Tranche 1 Warrants of Noble Corporation plcNE WSNew York Stock Exchange
Tranche 2 Warrants of Noble Corporation plcNE WSANew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐





Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 8, 2025, Noble Corporation plc, a company incorporated in England and Wales (“Noble”), held an annual general meeting of the shareholders of Noble (the “Meeting”).
The specific voting results for the proposals, each of which is described in greater detail in Noble’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on March 27, 2025, follow below:

1.Resolution 1: The following individual was elected to the Company’s Board of Directors for a term that will expire at the annual general meeting in 2026:
NomineeForAgainstAbstainBroker Non-Votes
Patrice Douglas122,176,8914,378,09272,37612,790,644
2.Resolution 2: The following individual was re-elected to the Company’s Board of Directors for a term that will expire at the annual general meeting in 2026:
NomineeForAgainstAbstainBroker Non-Votes
Robert W. Eifler126,383,647172,20571,50712,790,644
3.Resolution 3: The following individual was re-elected to the Company’s Board of Directors for a term that will expire at the annual general meeting in 2026:
NomineeForAgainstAbstainBroker Non-Votes
Claus V. Hemmingsen114,569,76411,985,86371,73212,790,644
4.Resolution 4: The following individual was re-elected to the Company’s Board of Directors for a term that will expire at the annual general meeting in 2026:
NomineeForAgainstAbstainBroker Non-Votes
Alan J. Hirshberg124,451,5912,104,26171,50712,790,644
5.Resolution 5: The following individual was re-elected to the Company’s Board of Directors for a term that will expire at the annual general meeting in 2026:
NomineeForAgainstAbstainBroker Non-Votes
Kristin H. Holth126,282,654273,55671,14912,790,644
6.Resolution 6: The following individual was re-elected to the Company’s Board of Directors for a term that will expire at the annual general meeting in 2026:
NomineeForAgainstAbstainBroker Non-Votes
H. Keith Jennings125,913,768643,51370,07812,790,644
7.Resolution 7: The following individual was re-elected to the Company’s Board of Directors for a term that will expire at the annual general meeting in 2026:
NomineeForAgainstAbstainBroker Non-Votes
Charles M. Sledge124,639,9121,915,93171,51612,790,644
8.Resolution 8: The resolution to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2025 was approved.
ForAgainstAbstainBroker Non-Votes
130,276,7769,050,81790,410




9.Resolution 9: The resolution to re-appoint PricewaterhouseCoopers LLP as the Company’s UK statutory auditors, until the 2026 annual general meeting of shareholders, was approved.
ForAgainstAbstainBroker Non-Votes
130,274,3789,053,64289,983
10.Resolution 10: The resolution authorizing the Audit Committee to Determine UK Statutory Auditors’ Remuneration was approved.
ForAgainstAbstainBroker Non-Votes
138,469,736835,825112,442
11.Resolution 11: The resolution to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement was approved.
ForAgainstAbstainBroker Non-Votes
117,454,0363,057,4706,115,85312,790,644
12.Resolution 12: The resolution to approve the Directors’ Remuneration Report was approved.
ForAgainstAbstainBroker Non-Votes
123,432,5412,981,394213,42412,790,644
13.Resolution 13: The resolution to authorize the Board of Directors to Allot Shares was approved.
ForAgainstAbstainBroker Non-Votes
119,747,3126,749,811130,23612,790,644
14.Resolution 14: The resolution to authorize the Board of Director to Allot Shares without Rights of Pre-emption was approved.
ForAgainstAbstainBroker Non-Votes
117,517,2228,821,492288,64512,790,644
15.Resolution 15: The resolution approving the Terms of the Agreements and Counterparties, pursuant to which the Company may Purchase its Class A Ordinary Shares, was approved.
ForAgainstAbstainBroker Non-Votes
125,721,845784,933120,58112,790,644

Item 9.01.    Financial Statements and Exhibits.
(d)    Exhibits
EXHIBIT
NUMBERDESCRIPTION
Exhibit 104Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  NOBLE CORPORATION plc
Date:May 9, 2025  By: /s/ Jennie Howard
 Jennie Howard
 Senior Vice President, General Counsel and Corporate Secretary